An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7067-7067 ◽  
Author(s):  
P. A. Janne ◽  
G. R. Simon ◽  
C. J. Langer ◽  
R. N. Taub ◽  
A. Dowlati ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Clinical Trial ◽  
Pleural Mesothelioma ◽  
Front Line ◽  
Line Chemotherapy

A phase II study of pemetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelioma (MPM)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7172-7172 ◽  
Author(s):  
G. L. Ceresoli ◽  
P. A. Zucali ◽  
A. Favaretto ◽  
M. Marangolo ◽  
G. Del Conte ◽  
...  
Keyword(s):  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Study ◽  
Pleural Mesothelioma ◽  
Front Line ◽  
Line Chemotherapy

scholarly journals Phase II Clinical Trial of First or Second-Line Treatment with Bortezomib in Patients with Malignant Pleural Mesothelioma

2012 ◽  
Vol 7 (9) ◽  
pp. 1466-1470 ◽  
Author(s):  
Dean A. Fennell ◽  
Cliona McDowell ◽  
Sara Busacca ◽  
Glen Webb ◽  
Brian Moulton ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Clinical Trial ◽  
Pleural Mesothelioma ◽  
Line Treatment ◽  
Second Line

Taxotere in malignant pleural mesothelioma. A phase II clinical trial

Lung Cancer ◽  
2000 ◽  
Vol 29 (1) ◽  
pp. 19 ◽  
Author(s):  
D.A Vorobiof ◽  
M.R Chasen ◽  
R Abratt ◽  
B Rapoport ◽  
N Cronje ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Clinical Trial ◽  
Pleural Mesothelioma
Sign in / Sign up

Export Citation Format

Share Document